These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 7862819)
21. Behavioral measures of anxiety during opiate withdrawal. Grasing K; Wang A; Schlussman S Behav Brain Res; 1996 Oct; 80(1-2):195-201. PubMed ID: 8905143 [TBL] [Abstract][Full Text] [Related]
22. Quantifiable dose-dependent withdrawal after morphine discontinuation in a rat model. Langerman L; Piscoun B; Bansinath M; Shemesh Y; Turndorf H; Grant GJ Pharmacol Biochem Behav; 2001 Jan; 68(1):1-6. PubMed ID: 11274701 [TBL] [Abstract][Full Text] [Related]
23. The physical dependence liability of butorphanol: a comparative study with morphine. Horan P; Ho IK Eur J Pharmacol; 1991 Oct; 203(3):387-91. PubMed ID: 1773823 [TBL] [Abstract][Full Text] [Related]
24. Morphine withdrawal activates hypothalamic-pituitary-adrenal axis and heat shock protein 27 in the left ventricle: the role of extracellular signal-regulated kinase. Martínez-Laorden E; Hurle MA; Milanés MV; Laorden ML; Almela P J Pharmacol Exp Ther; 2012 Sep; 342(3):665-75. PubMed ID: 22647273 [TBL] [Abstract][Full Text] [Related]
25. Role of withdrawal in reinstatement of morphine-conditioned place preference. Lu L; Chen H; Su W; Ge X; Yue W; Su F; Ma L Psychopharmacology (Berl); 2005 Aug; 181(1):90-100. PubMed ID: 15739075 [TBL] [Abstract][Full Text] [Related]
26. Brain corticotropin-releasing factor mediates 'anxiety-like' behavior induced by cocaine withdrawal in rats. Sarnyai Z; Bíró E; Gardi J; Vecsernyés M; Julesz J; Telegdy G Brain Res; 1995 Mar; 675(1-2):89-97. PubMed ID: 7796157 [TBL] [Abstract][Full Text] [Related]
27. Cholecystokinin-B receptor antagonists attenuate morphine dependence and withdrawal in rats. Lu L; Huang M; Liu Z; Ma L Neuroreport; 2000 Mar; 11(4):829-32. PubMed ID: 10757528 [TBL] [Abstract][Full Text] [Related]
28. Central beta 1-adrenergic receptors are involved in CRF-induced defensive withdrawal. Yang XM; Dunn AJ Pharmacol Biochem Behav; 1990 Aug; 36(4):847-51. PubMed ID: 2170999 [TBL] [Abstract][Full Text] [Related]
29. Differential effects of morphine withdrawal on cerebral beta 1- and beta 2-adrenergic receptors. Kuriyama K; Muramatsu M; Ohkuma S; Tamura J; Ping ZP J Neurosci Res; 1981; 6(6):749-55. PubMed ID: 6278157 [TBL] [Abstract][Full Text] [Related]
30. Further studies of the role of opioid receptors in the nigra in the morphine withdrawal syndrome. Baumeister AA; Richard AL; Richmond-Landeche L; Hurry MJ; Waguespack AM Neuropharmacology; 1992 Sep; 31(9):835-41. PubMed ID: 1359441 [TBL] [Abstract][Full Text] [Related]
31. Repeated experience with naloxone facilitates acute morphine withdrawal: potential role for conditioning processes in acute opioid dependence. Schulteis G; Morse AC; Liu J Pharmacol Biochem Behav; 2003 Dec; 76(3-4):493-503. PubMed ID: 14643849 [TBL] [Abstract][Full Text] [Related]
32. A double-blind, placebo-controlled trial of amantadine, propranolol, and their combination for the treatment of cocaine dependence in patients with severe cocaine withdrawal symptoms. Kampman KM; Dackis C; Lynch KG; Pettinati H; Tirado C; Gariti P; Sparkman T; Atzram M; O'Brien CP Drug Alcohol Depend; 2006 Nov; 85(2):129-37. PubMed ID: 16697124 [TBL] [Abstract][Full Text] [Related]
34. 5-HT2 receptor antagonists given in the acute withdrawal from daily cocaine injections can reverse established sensitization. Davidson C; Lazarus C; Xiong X; Lee TH; Ellinwood EH Eur J Pharmacol; 2002 Oct; 453(2-3):255-63. PubMed ID: 12398913 [TBL] [Abstract][Full Text] [Related]
35. Effect of environmental enrichment on physical and psychological dependence signs and voluntary morphine consumption in morphine-dependent and morphine-withdrawn rats. Hammami-Abrand Abadi A; Miladi-Gorji H; Bigdeli I Behav Pharmacol; 2016 Apr; 27(2-3 Spec Issue):270-8. PubMed ID: 26397757 [TBL] [Abstract][Full Text] [Related]
36. Beta-adrenergic receptors are involved in stress-related behavioral changes. Gorman AL; Dunn AJ Pharmacol Biochem Behav; 1993 May; 45(1):1-7. PubMed ID: 8100069 [TBL] [Abstract][Full Text] [Related]
37. Management of drug and alcohol withdrawal. Castro VJ N Engl J Med; 2003 Jul; 349(4):405-7; author reply 405-7. PubMed ID: 12879899 [No Abstract] [Full Text] [Related]
38. Rats with extended access to cocaine exhibit increased stress reactivity and sensitivity to the anxiolytic-like effects of the mGluR 2/3 agonist LY379268 during abstinence. Aujla H; Martin-Fardon R; Weiss F Neuropsychopharmacology; 2008 Jul; 33(8):1818-26. PubMed ID: 17895914 [TBL] [Abstract][Full Text] [Related]
39. Conditioned sucrose aversions produced by naloxone-precipitated withdrawal from acutely administered morphine. McDonald RV; Parker LA; Siegel S Pharmacol Biochem Behav; 1997 Dec; 58(4):1003-8. PubMed ID: 9408206 [TBL] [Abstract][Full Text] [Related]
40. Spontaneous vs. naloxone-induced abstinence in dependent rats self-administering L-alpha-acetylmethadol (LAAM) or morphine. Young GA; Steinfels GF; Khazan N Pharmacol Biochem Behav; 1979 Apr; 10(4):585-9. PubMed ID: 223173 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]